Pediatric drug development (Record no. 629)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01774nam a2200349 a 4500 |
| 245 00 - TITLE STATEMENT | |
| Title | Pediatric drug development |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 2nd ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication | Hoboken, N.J. : |
| Name of publisher | Wiley, |
| Year of publication | 2013. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Number of Pages | xiv, 610 p. : |
| Other physical details | ill. (some col.) |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | pt. I. Past, present, and future of pediatric drug development -- pt. II. Ethical underpinnings -- pt. III. Regulatory guidelines for pediatric drug development -- pt. IV. Preclinical safety assessment -- pt. V. Pharmacological principles in pediatric drug development -- pt. VI. Clinical trial operations -- pt. VII. Clinical trial operations and good clinical trials -- pt. VIII. Clinical efficacy and safety endpoints -- pt. IX. Formulation, chemistry and manufacturing controls. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical Term | Pediatric pharmacology. |
| Topical Term | Drug development. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mulberg, Andrew E. |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://site.ebrary.com/lib/rucke/Doc?id=10713652 |
No items available.